Evidence map›Paper›PMID 34760017›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2021

Tetrahydropalmatine Alleviates Hyperlipidemia by Regulating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammasome Activation by Inhibiting the TLR4-NF-

Ke Ding, Linjun Chen, Jiaqi He, Jiahong Wang, Chaohui Yu, Hui Wang

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Validation of the Anticolitis Efficacy of the Jian-Wei-Yu-Yang Formula.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ke DingTraditional Chinese Medicine Dispensary, Zhejiang Provincial Hospital of Chinese Medicine, Hangzhou, Zhejiang 310000, China.ORCID https://orcid.org/0000-0002-3877-0604
Linjun ChenGeneral Surgery, Zhejiang Youth Hospital, Hangzhou, Zhejiang 310000, China.ORCID https://orcid.org/0000-0002-4755-0064
Jiaqi HeTraditional Chinese Medicine Dispensary, Zhejiang Provincial Hospital of Chinese Medicine, Hangzhou, Zhejiang 310000, China.
Jiahong WangTraditional Chinese Medicine Dispensary, Zhejiang Provincial Hospital of Chinese Medicine, Hangzhou, Zhejiang 310000, China.ORCID https://orcid.org/0000-0001-7596-6094
Chaohui YuTraditional Chinese Medicine Dispensary, Zhejiang Provincial Hospital of Chinese Medicine, Hangzhou, Zhejiang 310000, China.ORCID https://orcid.org/0000-0002-5616-1335
Hui WangTraditional Chinese Medicine Dispensary, Zhejiang Provincial Hospital of Chinese Medicine, Hangzhou, Zhejiang 310000, China.ORCID https://orcid.org/0000-0003-0108-8254
Zhejiang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperlipidemia (HLP) is a lipid metabolism disorder that can induce a series of cardiovascular and cerebrovascular diseases, such as atherosclerosis, myocardial infarction, coronary heart disease, and stroke, which seriously threaten human health. Tetrahydropalmatine (THP) is a component of the plant

Identifiers

PMID34760017
PMCPMC8575622
OpenAlexW3209588336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.